Cyclopropanecarboxylic acid anhydride, 90.0%, 250mg

(4R,4'R)-2,2'-[2-PHENYL-1-(PHENYLMETHYL)ETHYLIDENE]BIS[4-(1-METHYLETHYL)-4,5-DIHYDROOXAZOLE, 95%, 100mg

(S,E)-ethyl 5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpent-2-enoate, 96%, 250mg

Solution standard ICP de gadolinium, ROTI®Star, 1000 mg/l Gd, densité (D) ~1 g/cm³

4-(Trifluoromethylthio)benzyl Bromide>97.0%(GC)1g

Methyl 3-hydroxy-5-methoxybenzoate, 95.0%, 1g

2,4-Dinitroaniline>99.0%(GC)500g

Objectif à contraste de phase Plan PLPH S40x/0,65

(3,3-DIFLUOROCYCLOHEXYL)METHANOL, 95%, 100mg

Agent de réticulation UV, lumière à ondes courtes, 254 nm 1 pièce

Phenethyl Benzoate>98.0%(GC)25g

Ethyl 7-Chloroimidazo[1,2-a]pyridine-2-carboxylate, 97.0%, 1g

(2-ISOPROPYLPYRIMIDIN-5-YL)BORONIC ACID PINACOL ESTER, 95.0%, 250mg